High-potency B-complex formulation options containing vitamins B1, B2, B3, B5 and B6 for nutritional supplementation and correction of documented deficiencies under professional guidance.
Active ingredients: Thiamine Mononitrate (Vitamin B1), Riboflavin (Vitamin B2), Pyridoxine Hydrochloride (Vitamin B6), Niacinamide/Nicotinamide (Vitamin B3) and Calcium Pantothenate (Vitamin B5).
Formulation options supplied for development/registration: B1 10/50/100 mg; B2 10/15 mg; B6 3/10 mg; Niacinamide 50/100 mg; Calcium Pantothenate 10/50 mg. Final label claim must match the approved market-specific formula.
Therapeutic category: Vitamin B-Complex / Nutritional Supplement.
B2B enquiry: Contract manufacturing and export enquiries: +91 7710003340.
Thiamine Mononitrate + Riboflavin + Pyridoxine HCl + Niacinamide + Calcium Pantothenate Tablets is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.
Healthy Life Pharma Pvt. Ltd. offers manufacturing and B2B supply support for therapeutic B-complex tablets containing thiamine mononitrate, riboflavin, pyridoxine hydrochloride, niacinamide and calcium pantothenate.
These water-soluble B vitamins act as coenzymes in carbohydrate, protein and energy metabolism and support normal neurologic, skin and mucosal function. Higher-potency formulas may be used when clinically appropriate to correct or prevent specific vitamin deficiencies. Exact indications, strengths and claims should follow the approved product label and local regulations.
Manufacturing/export certifications and regulatory status should be verified against current valid documents before publication or tender submission.
| Product Name | Therapeutic B-Complex Tablets |
|---|---|
| Generic Description | Thiamine Mononitrate + Riboflavin + Pyridoxine HCl + Niacinamide + Calcium Pantothenate Tablets |
| Vitamin B1 | Thiamine Mononitrate: 10 mg / 50 mg / 100 mg formulation options |
| Vitamin B2 | Riboflavin: 10 mg / 15 mg formulation options |
| Vitamin B6 | Pyridoxine HCl: 3 mg / 10 mg formulation options |
| Vitamin B3 | Niacinamide (Nicotinamide): 50 mg / 100 mg formulation options |
| Vitamin B5 | Calcium Pantothenate: 10 mg / 50 mg formulation options |
| Dosage Form | Oral tablet; sugar-coated or film-coated presentation may be developed subject to approved specification |
| Therapeutic Class | Vitamin B-Complex / Nutritional Supplement |
| Standard | Market-specific pharmacopoeial or approved in-house specification, as applicable |
| Packaging / Shelf Life | To be confirmed from the approved stability data and registered pack |
The listed strengths are alternative formulation options from the supplied brief and should not be interpreted as one fixed tablet composition.
B-complex formulations require control of blend uniformity, moisture, light exposure and coating performance because individual vitamins differ in dose and stability.
Any specific excipients, binders, pigments, humidity limits, equipment or process claims should be published only if supported by the actual manufacturing record.
Finished-product testing should follow the registered specification and applicable pharmacopoeial requirements. Typical quality controls may include:
Any overages used to compensate for stability loss must be scientifically justified, documented and compliant with the target market's regulations.
This combination supplies several B vitamins with complementary metabolic roles:
Use may be appropriate for prevention or treatment of deficiencies when dietary intake is inadequate or requirements are increased. Specific disorders such as beriberi, pellagra, neurologic syndromes or severe deficiency can require targeted therapy and should not be self-treated with a general combination tablet.
Important: suspected Wernicke encephalopathy is a medical emergency and commonly requires urgent parenteral thiamine rather than relying on an oral B-complex tablet.
For B2B partners, product registration support may include technical documentation, specifications, analytical data and commercial documentation depending on the destination market and contractual scope.
Claims such as WHO-GMP, COPP, FSC, Star Export House status, exact shelf life and specific approved markets should be verified from current documentation before use.
Dose should follow the approved product label and the patient's nutritional/clinical requirements. Because the supplied brief contains several alternative strengths, a universal “one tablet two or three times daily” instruction is not appropriate for every possible formulation.
Exact storage temperature and shelf life should be based on approved stability data for the final formulation and pack.
For professional and B2B reference. Prescribing information, manufacturing claims, certification and market-specific approvals require verification.